Global DNA Testing/Diagnostics Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 102

Report ID: 3608

DNA Testing/Diagnostics is the determination of bloodlinesand the genetic diagnosis of vulnerabilities to inherited diseases.
With the rising incidences of genetic, infectious, and chronic diseases, reduction in prices of genetic sequencing, DNA Testing/Diagnostics growing adoption of precision medicine diagnostic techniques.
In 2018, the global DNA Testing/Diagnostics market size was 11200 million US$ and it is expected to reach 27000 million US$ by the end of 2025, with a CAGR of 11.6% during 2019-2025.

This report focuses on the global DNA Testing/Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the DNA Testing/Diagnostics development in United States, Europe and China.

The key players covered in this study
GE Healthcare
454 Life Sciences
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
Thermo Fisher Scientific
Illumina
Cephide
Hologic
Transgenomic
Siemens Healthcare
Roche Diagnostics
Qiagen
Affymetrix
Agilent Technologies

Market segment by Type, the product can be split into
PCR-Based Diagnostics
ISH Diagnostics
NGS DNA Diagnosis

Market segment by Application, split into
Hospital
Medical Research
Pharmacogenomics Diagnostic Testing

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global DNA Testing/Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the DNA Testing/Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of DNA Testing/Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global DNA Testing/Diagnostics Market Size Growth Rate by Type (2014-2025)
1.4.2 PCR-Based Diagnostics
1.4.3 ISH Diagnostics
1.4.4 NGS DNA Diagnosis
1.5 Market by Application
1.5.1 Global DNA Testing/Diagnostics Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Medical Research
1.5.4 Pharmacogenomics Diagnostic Testing
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 DNA Testing/Diagnostics Market Size
2.2 DNA Testing/Diagnostics Growth Trends by Regions
2.2.1 DNA Testing/Diagnostics Market Size by Regions (2014-2025)
2.2.2 DNA Testing/Diagnostics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 DNA Testing/Diagnostics Market Size by Manufacturers
3.1.1 Global DNA Testing/Diagnostics Revenue by Manufacturers (2014-2019)
3.1.2 Global DNA Testing/Diagnostics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global DNA Testing/Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 DNA Testing/Diagnostics Key Players Head office and Area Served
3.3 Key Players DNA Testing/Diagnostics Product/Solution/Service
3.4 Date of Enter into DNA Testing/Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global DNA Testing/Diagnostics Market Size by Type (2014-2019)
4.2 Global DNA Testing/Diagnostics Market Size by Application (2014-2019)

5 United States
5.1 United States DNA Testing/Diagnostics Market Size (2014-2019)
5.2 DNA Testing/Diagnostics Key Players in United States
5.3 United States DNA Testing/Diagnostics Market Size by Type
5.4 United States DNA Testing/Diagnostics Market Size by Application

6 Europe
6.1 Europe DNA Testing/Diagnostics Market Size (2014-2019)
6.2 DNA Testing/Diagnostics Key Players in Europe
6.3 Europe DNA Testing/Diagnostics Market Size by Type
6.4 Europe DNA Testing/Diagnostics Market Size by Application

7 China
7.1 China DNA Testing/Diagnostics Market Size (2014-2019)
7.2 DNA Testing/Diagnostics Key Players in China
7.3 China DNA Testing/Diagnostics Market Size by Type
7.4 China DNA Testing/Diagnostics Market Size by Application

8 Japan
8.1 Japan DNA Testing/Diagnostics Market Size (2014-2019)
8.2 DNA Testing/Diagnostics Key Players in Japan
8.3 Japan DNA Testing/Diagnostics Market Size by Type
8.4 Japan DNA Testing/Diagnostics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia DNA Testing/Diagnostics Market Size (2014-2019)
9.2 DNA Testing/Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia DNA Testing/Diagnostics Market Size by Type
9.4 Southeast Asia DNA Testing/Diagnostics Market Size by Application

10 India
10.1 India DNA Testing/Diagnostics Market Size (2014-2019)
10.2 DNA Testing/Diagnostics Key Players in India
10.3 India DNA Testing/Diagnostics Market Size by Type
10.4 India DNA Testing/Diagnostics Market Size by Application

11 Central & South America
11.1 Central & South America DNA Testing/Diagnostics Market Size (2014-2019)
11.2 DNA Testing/Diagnostics Key Players in Central & South America
11.3 Central & South America DNA Testing/Diagnostics Market Size by Type
11.4 Central & South America DNA Testing/Diagnostics Market Size by Application

12 International Players Profiles
12.1 GE Healthcare
12.1.1 GE Healthcare Company Details
12.1.2 Company Description and Business Overview
12.1.3 DNA Testing/Diagnostics Introduction
12.1.4 GE Healthcare Revenue in DNA Testing/Diagnostics Business (2014-2019)
12.1.5 GE Healthcare Recent Development
12.2 454 Life Sciences
12.2.1 454 Life Sciences Company Details
12.2.2 Company Description and Business Overview
12.2.3 DNA Testing/Diagnostics Introduction
12.2.4 454 Life Sciences Revenue in DNA Testing/Diagnostics Business (2014-2019)
12.2.5 454 Life Sciences Recent Development
12.3 Abbott Laboratories
12.3.1 Abbott Laboratories Company Details
12.3.2 Company Description and Business Overview
12.3.3 DNA Testing/Diagnostics Introduction
12.3.4 Abbott Laboratories Revenue in DNA Testing/Diagnostics Business (2014-2019)
12.3.5 Abbott Laboratories Recent Development
12.4 Beckman Coulter
12.4.1 Beckman Coulter Company Details
12.4.2 Company Description and Business Overview
12.4.3 DNA Testing/Diagnostics Introduction
12.4.4 Beckman Coulter Revenue in DNA Testing/Diagnostics Business (2014-2019)
12.4.5 Beckman Coulter Recent Development
12.5 Bio-Rad Laboratories
12.5.1 Bio-Rad Laboratories Company Details
12.5.2 Company Description and Business Overview
12.5.3 DNA Testing/Diagnostics Introduction
12.5.4 Bio-Rad Laboratories Revenue in DNA Testing/Diagnostics Business (2014-2019)
12.5.5 Bio-Rad Laboratories Recent Development
12.6 Thermo Fisher Scientific
12.6.1 Thermo Fisher Scientific Company Details
12.6.2 Company Description and Business Overview
12.6.3 DNA Testing/Diagnostics Introduction
12.6.4 Thermo Fisher Scientific Revenue in DNA Testing/Diagnostics Business (2014-2019)
12.6.5 Thermo Fisher Scientific Recent Development
12.7 Illumina
12.7.1 Illumina Company Details
12.7.2 Company Description and Business Overview
12.7.3 DNA Testing/Diagnostics Introduction
12.7.4 Illumina Revenue in DNA Testing/Diagnostics Business (2014-2019)
12.7.5 Illumina Recent Development
12.8 Cephide
12.8.1 Cephide Company Details
12.8.2 Company Description and Business Overview
12.8.3 DNA Testing/Diagnostics Introduction
12.8.4 Cephide Revenue in DNA Testing/Diagnostics Business (2014-2019)
12.8.5 Cephide Recent Development
12.9 Hologic
12.9.1 Hologic Company Details
12.9.2 Company Description and Business Overview
12.9.3 DNA Testing/Diagnostics Introduction
12.9.4 Hologic Revenue in DNA Testing/Diagnostics Business (2014-2019)
12.9.5 Hologic Recent Development
12.10 Transgenomic
12.10.1 Transgenomic Company Details
12.10.2 Company Description and Business Overview
12.10.3 DNA Testing/Diagnostics Introduction
12.10.4 Transgenomic Revenue in DNA Testing/Diagnostics Business (2014-2019)
12.10.5 Transgenomic Recent Development
12.11 Siemens Healthcare
12.12 Roche Diagnostics
12.13 Qiagen
12.14 Affymetrix
12.15 Agilent Technologies

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details